What a Class I Recall Means for a Medical Device

A Class I recall means FDA has found a reasonable probability that using or encountering a medical device could cause serious harm or death. It is the agency's highest recall-risk category.

The designation describes the danger associated with the recall, not what every patient must do next. The response may involve removing a device, correcting it where it is used, monitoring patients or providing new instructions. The FDA explains that recall actions depend on the device and hazard.

Table of Contents

• It measures recall risk, not device type
• Does every recalled device have to be returned?
• What should patients and providers do?
• Who starts the recall, and when does FDA post it?
• A Class I recall may call for reprogramming

It measures recall risk, not device type

A recall's Class I label is easy to confuse with the regulatory class assigned to a device before marketing. They are separate classifications. fda assigns recall Classes I through III after assessing the health hazard and possible legal violation.

Class I identifies the most serious recall risk; it does not describe the device's original regulatory category. The classification also does not mean every affected device has already injured someone. It reflects a reasonable probability of serious consequences or death from use or exposure.

Does every recalled device have to be returned?

No. A medical-device recall may remove a product, but it can also correct the problem where the device is used. Depending on the recall, the response may include inspection, repair, adjustment, relabeling, patient notification or monitoring.

FDA says a recall does not necessarily require returning the device. That distinction matters especially for implanted devices. Recall status alone does not mean an implant should be removed. A clinician may need to compare the risks of removal with the risks of leaving it in place.

What should patients and providers do?

Follow the instructions for the affected product, not the class I label by itself. The label explains the seriousness of the hazard; the recall notice explains the appropriate response.

A patient, caregiver or health professional should: Hospitals, distributors and other direct customers may receive additional duties. The recalling firm must tell affected direct accounts what to do, instruct them to stop further distribution or use of remaining affected products, and request downstream notification when appropriate.

• Check whether the device is covered by the recall notice.
• Identify whether the prescribed action is inspection, repair, adjustment, reprogramming, monitoring, relabeling or removal.
• Follow any patient-notification or monitoring directions.
• Consult the treating clinician before drawing conclusions about an implanted device.
• Avoid assuming that "recall" always means immediate replacement or return.

Who starts the recall, and when does FDA post it?

Manufacturers, distributors or other responsible firms usually begin device recalls voluntarily and notify FDA. FDA can order a recall when a firm fails to act on a device that presents a health risk, although the agency says such orders are rare. A company may warn customers and start corrective action before FDA formally classifies the recall.

Therefore, the FDA classification or database-posting date may not be the date the recall began. FDA's enforcement-report guidance explains this timing distinction. After classification, FDA monitors the response. It terminates the recall only after determining that reasonable corrective or removal efforts were made and the affected product was properly addressed in proportion to the hazard.

A Class I recall may call for reprogramming

A 2023 Medtronic recall shows why readers must look beyond the classification. FDA reported that 348,616 defibrillators were recalled because low or absent high-voltage therapy could fail to correct a life-threatening abnormal heart rhythm.

The prescribed response included reprogramming rather than preventive replacement of every implant. FDA's Medtronic notice describes the risk and corrective action.

You Might Also Like

• FDA Issues Class I Recalls for Resmed Astral Ventilators and Abiomed Introducer Kits
• Massachusetts Law Gives Physicians Discretion Over Abortions After 24 Weeks
• How the FDA Approves a New Drug

Browse more: Business & Economy | Courts & Justice | Health & Science | Media & Verification | Money & Consumer